Journal
CELL CYCLE
Volume 5, Issue 16, Pages 1799-1807Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.5.16.3109
Keywords
metastasis; quiescence; ERK; p38; unfolded protein response; uPAR; tumor dormancy; microenvironment
Categories
Funding
- NCI NIH HHS [R01 CA109182-02, R01 CA109182-01A1, CA109182, R01 CA109182, R01 CA109182-04, R01 CA109182-03] Funding Source: Medline
Ask authors/readers for more resources
Cancer dormancy is a poorly understood stage of cancer progression. However, the ability to control this step of the disease offers novel therapeutic opportunities. Here we summarize recent findings that implicate the extracellular matrix and adhesion receptor signaling in the escape or induction of tumor dormancy. We further review evidence suggesting that imbalances in the activity ratio of ERK to p38 signaling may determine the fate (i.e.,tumorigenicity vs. dormancy) of different carcinoma cells. Special attention is placed on the mechanisms that p38 signaling regulates during the induction of dormancy and how modulation of these pathways may offer a therapeutic opportunity. We also review evidence for a novel drug-resistance mechanism in dormant tumor cells that when blocked may enable killing of dormant tumor cells. Finally, we explore the notion that dormancy of tumor cells may be the result of a selective adaptive response that allows disseminated tumor cells to pause their growth and cope with stress signaling imposed by dissemination and/or treatment until growth can be restored.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available